MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
38.05
+1.70 (4.68%)
At close: Apr 2, 2025, 4:00 PM
37.00
-1.05 (-2.76%)
After-hours: Apr 2, 2025, 7:33 PM EDT

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
180.43451.1739.518.04
Short-Term Investments
267.659.8432.61-
Cash & Short-Term Investments
448.03511.0172.118.04
Cash Growth
-12.32%608.60%797.08%-
Other Receivables
2.841.060.220.15
Receivables
2.841.060.220.15
Prepaid Expenses
23.422.14.181.45
Total Current Assets
474.29514.1776.519.64
Property, Plant & Equipment
3.643.950.330.05
Other Long-Term Assets
-8.42--
Total Assets
477.93526.5476.849.68
Accounts Payable
0.220.330.160.03
Accrued Expenses
20.238.077.244.76
Short-Term Debt
---15
Current Portion of Leases
1.371.20.15-
Current Income Taxes Payable
0.640.370.110.06
Other Current Liabilities
---1.23
Total Current Liabilities
22.469.977.6721.09
Long-Term Leases
1.462.50.13-
Total Liabilities
24.5413.058.0821.33
Common Stock
0.010.010.010.04
Additional Paid-In Capital
677.41609.97129.1942.06
Retained Earnings
-235.59-116.66-80.65-53.64
Treasury Stock
----0.01
Comprehensive Income & Other
52.360.35-0.17
Total Common Equity
446.83495.6848.9-11.72
Minority Interest
6.5717.8219.87-
Shareholders' Equity
453.39513.4968.77-11.65
Total Liabilities & Equity
477.93526.5476.849.68
Total Debt
2.833.70.2815
Net Cash (Debt)
445.2507.3171.83-6.96
Net Cash Growth
-12.24%606.24%--
Net Cash Per Share
7.0810.332.45-0.89
Filing Date Shares Outstanding
63.2862.8739.150.3
Total Common Shares Outstanding
63.0860.4738.980.3
Working Capital
451.82504.268.85-11.45
Book Value Per Share
7.088.201.25-38.57
Tangible Book Value
446.83495.6848.9-11.72
Tangible Book Value Per Share
7.088.201.25-38.57
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q